Fulltext:
220091.pdf
Embargo:
until further notice
Size:
1.061Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2020Source
Otolaryngology-Head and Neck Surgery, 162, 4, (2020), pp. 446-457ISSN
Annotation
01 april 2020
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Otorhinolaryngology
Medical Oncology
Radiation Oncology
Oral and Maxillofacial Surgery
Journal title
Otolaryngology-Head and Neck Surgery
Volume
vol. 162
Issue
iss. 4
Page start
p. 446
Page end
p. 457
Subject
Radboudumc 12: Sensory disorders DCMN: Donders Center for Medical Neuroscience; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Medical Oncology - Radboud University Medical Center; Oral and Maxillofacial Surgery - Radboud University Medical Center; Otorhinolaryngology - Radboud University Medical Center; Radiation Oncology - Radboud University Medical CenterAbstract
OBJECTIVE: An increased interval between symptomatic disease and treatment may negatively influence oncologic and/or functional outcomes in head and neck cancer (HNC). This systematic review aims to provide insight into the effects of time to treatment intervals on oncologic and functional outcomes in oral cavity, pharyngeal, and laryngeal cancer. DATA SOURCES: PubMed, EMBASE, and Cochrane library were searched. REVIEW METHODS: All studies on delay or time to diagnosis or treatment in oral, pharyngeal, and laryngeal cancer were included. Quality assessment was performed with an adjusted version of the Newcastle-Ottawa scale. Outcomes of interest were tumor volume, stage, recurrence, survival, patient-reported outcome measures (PROMs), toxicity, and functionality after treatment. RESULTS: A total of 51 studies were included. Current literature on the influence of delay in HNC is inconsistent but indicates higher stage and worse survival with longer delay. The effects on PROMs, toxicity, and functional outcome after treatment have not been investigated. The inconsistencies in outcomes were most likely caused by factors such as heterogeneity in study design, differences in the definitions of delay, bias of results, and incomplete adjustment for confounding factors in the included studies. CONCLUSION: Irrespective of the level of evidence, the unfavorable effects of delay on oncologic, functional, and psychosocial outcomes are undisputed. Timely treatment while maintaining high-quality diagnostic procedures and decision making reflects good clinical practice in our opinion. This review will pose practical and logistic challenges that will have to be overcome.
This item appears in the following Collection(s)
- Academic publications [246164]
- Electronic publications [133744]
- Faculty of Medical Sciences [93268]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.